SHL TELEMEDICINE LTD Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022
Cash flows from operating activities:
Net profit (loss)
Adjustments required to reconcile net profit (loss) to net cash provided by (used) in operating activities:
Income and expenses not involving operating cash flows:
Depreciation and amortization
Impairment of Goodwill
Impairment of intangible assets
Capital loss from disposals of property and equipment
Impairment of property, and equipment
Capital gain from amendment of lease liabilities
Change in employee benefit liabilities, net
Financial income, net
Valuation loss (gain) from short-term investments
Cost of share-based payments
Tax expenses
Income and expenses not involving operating cash flows
Changes in operating assets and liabilities:
Increase in trade receivables, net
Decrease in deferred taxes
Increase in inventory
Increase in prepaid expenses
Decrease (increase) in other accounts receivable
Increase (decrease) in trade payables
Decrease in deferred revenues
Increase in other accounts payable
Changes in operating assets and liabilities
Cash paid and received:
Interest received
Interest paid
Income tax received
Income taxes paid
Cash paid and received
Net cash used in operating activities
Cash flows from investing activities:
Purchase of property and equipment
Acquisition of subsidiaries
Investment in intangible assets
Investment in short-term deposits
Proceeds from short-term deposits
Proceeds From Sale Of Fixed Assets
Purchase of short-term investments
Proceeds from sale of short-term investments
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from issue of share options liability
Dividend paid to non-controlling interests
Payment of lease liabilities
Proceeds from issue of share capital, net
Exercise of share options
Payment of long-term loans
Payment of liability to underwriters
Net cash provided by (used in) financing activities
Effect of exchange rate changes on cash and cash equivalents
Increase (decrease) in cash and cash equivalents
Cash and cash equivalents at the beginning of the year
Cash and cash equivalents at the end of the year
Non-cash transactions:
Right-of-use asset recognized with corresponding lease liability
Incurrence Of Liability For Acquisition Of Non-controlling Interests
Liability derecognized and recorded in equity upon exercise of share options

Comments